We are monitoring the impact of COVID-19 on APAC Tumor Ablation Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 431
Share on
Share on

APAC Tumor Ablation Market Research Report – Segmented By Technology, Treatment, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 431
Pages: 137

APAC Tumor Ablation Market Size (2021 to 2026)

The size of the tumor ablation market in the Asia Pacific is predicted to be worth USD 0.20 Billion by 2026 from USD 0.09 Billion in 2021, growing at a CAGR of 16.3% from 2021 to 2026.

The increasing prevalence of cancer across the APAC is driving the Tumor ablation market. Also, the rising demand for minimally invasive tumor ablation techniques and safer therapeutics options augment the market growth during the forecast period. In addition, the rising number of initiatives taken by the government for creating awareness among the people and increasing investment by the government and private organizations are encouraging market growth. 

The demand for minimally invasive cancer treatments has been increased significantly in the recent past. As a result, key market participants in this region invest in developing technological advancements in Tumor ablation to enhance cost-effectiveness, portability, and accuracy. The advantages of this technology are the improved volume of tumor ablation, high-temperature stability, minimal ablation pain, and optimum cystic mass heating. Therefore, this segment's growth is likely to be aided by such benefits.

The senior population is further accelerating the market growth, as the growing geriatric population is more prone to various chronic diseases, such as cancer, diabetes, and others. Emerging market entrants and major manufacturers, on the other hand, are actively spending in R&D to create innovative products that will expand the clinical application profile of the tumor ablation market. Further, the increasing inclination of surgeons and patients towards minimally invasive procedures owing to the advantages like speedy recovery, patient comfort, and reduced work time area unit the factors expected to drive the market. Moreover, the increasing population in developing countries such as India and China provides lucrative growth opportunities to the market players and contributes to the APAC regional market growth. 

Various governments' cost-cutting initiatives and continuing healthcare reforms are expected to hinder the tumor ablation market's expansion during the forecast period. In addition, the tumor ablation market will face a challenge as regulatory standards become more stringent, resulting in a considerable increase in product launch gestation periods.

This research report on the APAC tumor ablation market has been segmented and sub-segmented into the following categories:

By Technology: 

  • Radiofrequency Ablation Devices
  • Microwave Ablation Devices
  • Cryoablation Devices
  • Other Ablation Devices

By Treatment: 

  • Surgical Ablation
  • Laparoscopic Ablation
  • Percutaneous Ablation

By Application: 

  • Liver Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostrate Metastasis
  • Other Cancer

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the Asia Pacific is estimated to be the fastest-growing region in the global market due to the high population base and favorable economic developments in the area.

The China tumor ablation market is the largest in the Asia Pacific region, accounting for a significant share due to its massive population. Furthermore, the market is likely to grow due to its higher purchasing parity, technological advancement in Tumor ablation, and growing healthcare expenditure. 

In contrast, the Indian tumor ablation market is estimated to be the fastest-growing due to increasing government support and healthcare spending.

On the other hand, countries like Japan and Australia are more likely to witness a promising share in the tumor ablation market and contribute to the Asia Pacific regional market growth. 

KEY MARKET PLAYERS:

Companies playing a promising role in the APAC tumor ablation market profiled in this report are Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 By Technology                                           

                                5.1.1 Radiofrequency Ablation Devices                 

                                5.1.2 Microwave Ablation Devices                           

                                5.1.3 Cryoablation Devices                          

                                5.1.4 Other Ablation Devices                      

                5.2 By Treatment                                            

                                5.2.1 Surgical Ablation                   

                                5.2.2 Laparoscopic Ablation                        

                                5.2.3 Percutaneous Ablation                      

                5.3 By Application                                           

                                5.3.1 Liver Cancer                            

                                5.3.2 Breast Cancer                        

                                5.3.3 Lung Cancer                            

                                5.3.4 Prostrate Metastasis                          

                                5.3.5 Other Cancers                       

6. Geographical Analysis                                                              

                6.3 Asia-Pacific                                 

                                6.1 Introduction                               

                                6.2 China                             

                                6.3 India                              

                                6.4 Japan                            

                                6.5 South Korea                               

                                6.6 Australia                      

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Medtronic Plc.                                           

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                             

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Angiodynamics                                         

                8.3 Mermaid Medical                                    

                8.4 HealthTronics                                            

                8.5 Galil Medical Inc.                                      

                8.6 EDAP TMS S.A.                                          

                8.7 Boston Scientific Corporation                                             

                8.8 SonaCare Medical                                    

                8.9 Misonix, Inc.                                              

                8.10 Neuwave Medical, Inc.                                       

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Tumor Ablation Market By Region, From 2021 to 2026 (USD Million)
  2. Asia-Pacific Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  3. Asia-Pacific Radiofrequency Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  4. Asia-Pacific Microwave Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  5. Asia-Pacific Cryoablation Devices Market By Region, From 2021 to 2026 (USD Million)
  6. Asia-Pacific other Ablation Devices Market By Region, From 2021 to 2026 (USD Million)
  7. Asia-Pacific Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  8. Asia-Pacific Surgical Ablation Market By Region, From 2021 to 2026 (USD Million)
  9. Asia-Pacific Laparoscopic Ablation Market By Region, From 2021 to 2026 (USD Million)
  10. Asia-Pacific Percutaneous Ablation Market By Region, From 2021 to 2026 (USD Million)
  11. Asia-Pacific Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  12. Asia-Pacific Liver Cancer Market By Region, From 2021 to 2026 (USD Million)
  13. Asia-Pacific Breast Cancer Market By Region, From 2021 to 2026 (USD Million)
  14. Asia-Pacific Lung Cancer Market By Region, From 2021 to 2026 (USD Million)
  15. Asia-Pacific Prostrate Metastasis Market By Region, From 2021 to 2026 (USD Million)
  16. Asia-Pacific other cancer Market By Region, From 2021 to 2026 (USD Million)
  17. China Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  18. China Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  19. China Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  20. India Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  21. India Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  22. India Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  23. Japan Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  24. Japan Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  25. Japan Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  26. South Korea Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  27. South Korea Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  28. South Korea Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)
  29. Australia Tumor Ablation Market By Technology, From 2021 to 2026 (USD Million)
  30. Australia Tumor Ablation Market By Treatment, From 2021 to 2026 (USD Million)
  31. Australia Tumor Ablation Market By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample